The StraightFrom® Buffy Coat CD8 MicroBead Kit has been developed for the rapid positive selection of CD8+ cells directly from one buffy coat using the MultiMACS™ Cell24 Separator Plus for semi-automated separation or a MACS® Separator for manual separation. No sample preparation is required, including density gradient centrifugation, erythrocyte lysis, wash steps, or cell count. Whole Blood Columns and Whole Blood Column Elution Buffer are included in the kit to allow direct processing of an entire buffy coat.
Related products for StraightFrom® Buffy Coat CD8 MicroBead Kit, human
The StraightFrom® Buffy Coat CD8 MicroBead Kit has been developed for the rapid positive selection of CD8+ cells directly from one buffy coat using the MultiMACS™ Cell24 Separator Plus for semi-automated separation or a MACS® Separator for manual separation. No sample preparation is required, including density gradient centrifugation, erythrocyte lysis, wash steps, or cell count. Whole Blood Columns and Whole Blood Column Elution Buffer are included in the kit to allow direct processing of an entire buffy coat.
In blood the CD8 antigen is expressed on human cytotoxic T cells and on a subset of CD16+ NK cells. The CD8 antigen acts as an accessory molecule in the recognition of MHC class I/peptide complexes by the TCR heterodimer on CD8+ cytotoxic T cells.
One entire buffy coat is labeled with StraightFrom® Buffy Coat CD8 MicroBeads and loaded onto Whole Blood Columns, which are placed in the magnetic field of a MultiMACS™ Cell24 Separator Plus or a MACS® Separator. After removing the column from the magnetic field, the magnetically retained CD8+ cells can be eluted as the positively selected cell fraction.
The purified CD8+ cells are well-suited for further flow cytometric, functional, or molecular analysis.
Separation of a buffy coat sample using the StraightFrom® Buffy Coat CD8 MicroBead Kit and the MultiMACS™ Cell24 Separator Plus with the Single-Column Adapter and Whole Blood Columns. Cells were fluorescently stained with CD3-PE, CD8‑APC, as well as CD45‑VioBlue® and analyzed by flow cytometry using the MACSQuant® Analyzer. Cells were triggered via CD45-VioBlue, cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence.